Regulatory frameworks for nanotechnology-based therapeutics are still evolving. Ensuring that these therapies meet stringent safety and efficacy standards is essential for gaining regulatory approval. Additionally, ethical considerations regarding the long-term impacts of nanomaterials on human health and the environment must be addressed.
